SYNGENE SYNVENT
LIVE

Serial Number

90065058

Owner

SYNGENE INTERNATIONAL LIMITED

Attorney

Mark A. Watkins

First Use Date

Aug 11, 2021

Filing Date

Jul 21, 2020

Add to watchlist:

No watchlists yet
View on USPTO

SYNGENE SYNVENT Trademark

Serial Number: 90065058 • Registration: 6695032

SYNGENE SYNVENT is a trademark filed by SYNGENE INTERNATIONAL LIMITED on July 21, 2020. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

SYNGENE INTERNATIONAL LIMITED (13 trademarks)

Biocon Special Economic Zone,Biocon Park
Link Rd, Bangalore Karnataka , IN

Entity Type: 03

Trademark Details

Filing Date

July 21, 2020

Registration Date

April 5, 2022

First Use Anywhere

August 11, 2021

First Use in Commerce

August 11, 2021

Published for Opposition

June 1, 2021

Goods & Services

Medical diagnostic testing, monitoring and reporting services; preparation of reports relating to medical matters; services for the testing of urine; pathology services for medical and diagnostic purposes

Scientific research and custom synthesis; scientific and clinical research in the field of medicine, pharmaceutical, nutraceuticals; scientific research and development; custom design and development of chemical reagents and biochemical assays; laboratory testing services for research purposes; testing of pharmaceuticals; chemical engineering; drug discovery services; pharmaceutical drug development services; pharmaceutical products development; development of pharmaceutical preparations and medicines; scientific study and research in the field of reproduction, husbandry, and general health of animal; biotechnology research for determining the neuronal survival of molecules in animal models; research and development services in the field of antibodies, antibody technology; custom design and development of chemical reagents and biochemical assays; design, engineering, research, development and testing services in the field of polymeric materials, polymer synthesis, and materials customization for medical, scientific, and technological applications; toxicology services; toxicity analysis; toxicity testing for research purposes; conducting clinical trials for scientific research for others; conducting clinical trials for others in the field of pharmaceutical products; providing medical and scientific research information in the field of clinical trials; conducting early evaluations in the field of new pharmaceuticals; DNA analysis services for scientific research purposes; laboratory research in the field of gene expression; blood analysis services for scientific research purposes; analysis of human tissues for medical research; scientific services relating to the isolation and cultivation of human tissues and cells for research purposes; preparation of reports relating to scientific and technical research; analysis in the field of molecular biology; contract research services relating to molecular sciences; biological cloning services; structural and functional analysis of genomes; scientific and medical laboratory services; services of a chemical and/or biological laboratory; laboratory research services relating to pharmaceuticals; research and development and consultation related thereto in the field of antibodies, antibody technology, chemistry, bioinformatics, biomedical devices, biologics, biotechnology, biotherapeutics, biology, biochemical preparations, cell line, chemoinformatic, genetics and genetic engineering, gene expression systems, in vitro research, inhalation pharmaceuticals, molecular sciences, micro-organisms, nutrition, ophthalmic preparations, pharmacogenetics, pharmacokinetics, pharmacology, pharmaceuticals, polymer, peptide synthesis, protein, and solid state characterization; toxicokinetic analysis and toxicology services; scientific and technological services, namely, scientific research, development, analysis, testing, engineering, extraction, synthesis, purification and production in the field of antibodies, active pharmaceutical ingredients (API), biomolecules, cell bank characterization, chirality, chromosome aberration, clinical chemistry, cloning vector, cyclotides, DNA, flow cytometry, gas chromatography mass spectrometry, genes, immuno-pharmaceuticals, in vitro irritation, large molecule, liquid chromatography mass spectrometry, microbials, monomers, nanoparticles, natural products, peptides, proteins, RNA, supercritical fluid chromatography, small molecules and vaccines; none of the aforesaid services relating to gel imaging and gel analysis applications and none of the aforesaid services in the field of agriculture, horticulture and forestry

Filing History

REGISTERED-PRINCIPAL REGISTER
Apr 5, 2022 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Mar 4, 2022 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Mar 3, 2022 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Feb 15, 2022 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 14, 2022 AITU
USE AMENDMENT FILED
Jan 27, 2022 IUAF
TEAS STATEMENT OF USE RECEIVED
Jan 27, 2022 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 27, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 1, 2021 NPUB
PUBLISHED FOR OPPOSITION
Jun 1, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 12, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 29, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 29, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 29, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 29, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 29, 2021 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 9, 2020 GNRN
NON-FINAL ACTION E-MAILED
Nov 9, 2020 GNRT
NON-FINAL ACTION WRITTEN
Nov 9, 2020 CNRT
ASSIGNED TO EXAMINER
Nov 4, 2020 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Aug 19, 2020 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 18, 2020 NWOS
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 29, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 29, 2020 TCCA
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 29, 2020 COAR
NEW APPLICATION ENTERED
Jul 24, 2020 NWAP